Sign In
Buy ADC
$76.32
-0.590 (-0.767%)
At Close: Aug 04, 2026
Agree Realty Declares Monthly Common and Preferred Dividends
04:05pm, Tuesday, 11'th Mar 2025
ROYAL OAK, Mich. , March 11, 2025 /PRNewswire/ -- Agree Realty Corporation (NYSE: ADC) (the "Company") today announced that its Board of Directors has authorized, and the Company has declared, a mont
Realty Income Vs. Agree Realty: What Is The Best REIT To Buy In 2025?
08:25am, Monday, 10'th Mar 2025
Realty Income and Agree Realty are two of the most popular REITs. Each offers unique pros and cons to investors. But which is the best to buy today?
A $5,000 Monthly Income Portfolio For A 'SWAN' Retirement
09:15am, Friday, 07'th Mar 2025
In this article, I share a three-category portfolio approach to achieve $5,000 of durable monthly current income streams. With durable monthly distributions, I mean well-mitigated dividend cut risk an
I Am Buying These 6% Yielding Blue-Chip Dividend Stocks
08:25am, Friday, 07'th Mar 2025
Dividend stocks are today undervalued. Tech stocks are exciting, but dividend growth stocks are more rewarding. Here are a few of my favorite high-yielding blue-chip dividend stocks.
7 Stocks I'm Buying As The U.S. Economy Starts To Crack
08:05am, Saturday, 01'st Mar 2025
I emphasize the importance of nonpartisan economic and investment analysis, highlighting how political biases can distort market expectations and investment decisions. Medicaid cuts would likely have
Akeso Announces First ADC Drug Clinical Trial, Marking a New Era for "IO 2.0 + ADC" Strategy
03:58am, Thursday, 27'th Feb 2025
HONG KONG , Feb. 27, 2025 /PRNewswire/ -- Akeso, Inc. (9926.HK) announced the first patient has been enrolled in the Phase I clinical trial of AK138 D1 for the treatment of advanced malignancies in Au
NEW YORK--(BUSINESS WIRE)--OS Therapies, Inc. (NYSE-A: OSTX), a clinical-stage biotechnology company advancing immunotherapies and targeted drug conjugates for cancer treatment, announced the formatio
The State Of REITs: February 2025 Edition
11:59am, Friday, 21'st Feb 2025
After a brutal December (-6.85%), the REIT sector averaged negative total returns again in January (-1.29%). Large cap (+0.30%) and mid cap REITs (+0.09%) averaged small gains in January, whereas smal
Agree Realty: When The Perfect Blend Of Consistency, Reliability, And Quality Meet
10:00am, Thursday, 20'th Feb 2025
Agree Realty's strong portfolio, minimal exposure to economic downturns, and robust growth potential make it a compelling long-term hold for income-focused investors. Despite recent inflation concerns
I'm Buying Up To 9% Yield For Recurring Income
02:00pm, Wednesday, 19'th Feb 2025
The 4% rule may be outdated due to current inflation and market conditions, making income stocks all the more relevant. I highlight two quality players who offer well-covered dividends and strong busi
Building on proven targeting of the F H AB domain, Sonnet's ADC platform offers flexible payload capacity and controllable drug-antibody ratios (DAR)
Agree Realty Vs. Realty Income: Accumulate Both REITs Offering Different Benefits
10:51am, Tuesday, 18'th Feb 2025
Agree Realty and Realty Income are two of my personal REIT holdings. ADC shows better stability and tenant credit quality. ADC's portfolio boasts 68.2% investment-grade tenants and a 99.6% occupancy r
Want to Collect Some Extra Income Each Month? Buy These 2 Top High-Yield Dividend Stocks.
10:56am, Monday, 17'th Feb 2025
Most dividend stocks make quarterly payments. That can make it more challenging for those seeking to align their income with their monthly expenses.
NORWOOD, Mass., Feb. 14, 2025 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) (“Corbus” or the “Company”), announced that data from its US and UK conducted first-in-hum
How To Build A $1,000 Monthly Dividend Income Stream From REITs
08:25am, Thursday, 13'th Feb 2025
REIT dividend yields are historically high. Even high-quality REITs are now offering high dividend yields. We build a REIT portfolio generating $1,000 monthly dividend income.
